Try Free

Iran War ceasefire; Trump and Vance feud with Pope — Searched - April 15, 2026

April 15, 2026 23m 4,514 words
▶ Watch original video

About this transcript: This is a full AI-generated transcript of Iran War ceasefire; Trump and Vance feud with Pope — Searched - April 15, 2026, published April 15, 2026. The transcript contains 4,514 words with timestamps and was generated using Whisper AI.

"Hey, what's going on? I'm Gio Benitez. It's Wednesday, April 15th. You've got questions, we've got answers. This is Search, where we're breaking down what you're asking right now in real time. So let's get right to it. We've got our Maya Ephraim right here. She oversees our online search trends. So"

[0:04] Hey, what's going on? I'm Gio Benitez. It's Wednesday, April 15th. You've got questions, [0:08] we've got answers. This is Search, where we're breaking down what you're asking right now [0:13] in real time. So let's get right to it. We've got our Maya Ephraim right here. She oversees [0:17] our online search trends. So Maya, what are people searching for right now? [0:21] Hi, Gio. How are you? The Iran work continues to be top of mind today. It had another bump [0:25] in search today after President Trump posted that he's reopening the Strait of Hormuz permanently. [0:30] More broadly, people are keeping tabs on the ceasefire and searching, [0:33] when does the ceasefire end? They clearly want to know if that April 22nd deadline is still the [0:38] date to watch. But beyond that, they also want to know what happens once it does end. [0:43] We're also seeing a massive surge in searches about the escalating feud between the Trump [0:47] administration and Pope Leo. Vice President J.D. Vance is telling the Pope to be more careful [0:51] when talking about theology. There was also that second photo of Trump with Jesus that the [0:55] president reposted this morning. And people just want to know what is going on and why the [1:00] administration is lashing out against the Pope. And finally, there's quieter but very steady [1:05] interest regarding a major legal win for Trump. An appeals court just stopped a contempt inquiry [1:10] into those controversial deportation flights from last year. The search intent right now [1:14] is very clear. People want to know who the judge is and why his investigation was just shut down. [1:19] Okay, three big stories. Maya, thank you so much for that. We're going to check back in with [1:23] you very soon. But first, let's dive a little deeper now into the story that you guys can't stop [1:27] asking about. Of course, that's the war with Ron. We've got Marcus Moore. He has been reporting from [1:32] the Middle East all week. He is right there in Beirut. Marcus, it is good to see you. So let's [1:36] start with this because Trump is saying that he will reopen the Strait of Hormuz. And a lot of people [1:41] are searching right now if he actually opened it. Yeah, it's a good question. Let me just tell you [1:48] what we know right now. We know that three tankers have crossed into or out of the Persian Gulf on April 14th. [1:54] That's according to tracking data from marine traffic. And since April 13th, a total of nine [2:00] tankers and boat carriers have crossed into or out of the Gulf, according to that data. And what we [2:06] have heard from experts, the picture that they're painting, is that since the launch of the U.S. [2:12] blockade, that there's been a reduced amount of traffic through the Strait of Hormuz and through [2:18] that area. But it would seem that some ships are getting through. But it's nothing like what you would [2:24] see on any regular day. And so there's still been an impact to traffic, marine traffic there. [2:30] So I guess it depends on what you consider as being open. And Gio, as you know, both Iran and [2:38] the U.S. are claiming authority over the Strait of Hormuz. So it remains a flashpoint. [2:42] Yeah, absolutely. Also a flashpoint here is people are searching to see if there are threats of [2:47] retaliation, right? Because we're also looking at Tehran blocking the Red Sea. That's another search [2:52] coming up. Yeah. So Iran has said that the blockade that the U.S. has has been implementing [3:01] is illegal and that it's a violation of the ceasefire in the war in Iran. Now, without saying [3:06] what, Iran has said that it will retaliate if the blockade continues and that they will exploit [3:13] vulnerabilities. Now, some fear that that response could indeed include the Houthis in blocking the [3:19] Bab al-Mandeb Strait, which is another critical supply route for energy and other goods around [3:24] the world. Gio, if that were to happen, it would no doubt have a significant impact and add to the [3:30] complexity of an already developing crisis in terms of energy and the global economy. [3:35] And Marcus, as you're seeing right there in the region, people obviously want this war to end. [3:41] And that's exactly what the search trends are also showing as well, because people are asking [3:44] if the war with Iran is over. So where do things stand right now? [3:48] Okay. No one has said, at least that I have seen, that this war is over. I mean, [3:55] there's a two-week ceasefire. There's a pause in place in the war in Iran and that it is holding, [4:01] but it remains a fragile ceasefire. And the Strait of Ramallah situation, just going back to that, [4:06] that's adding to concern that it could lead to an outbreak of new fighting. And then you also have [4:12] the fighting between Hezbollah and Israel here in Lebanon. Iran has said that there can be no [4:18] agreement on the war in Iran until there's a ceasefire here in Lebanon, Gio. [4:23] All right. Marcus Moore there in Beirut. Thank you for all of your reporting all week long. [4:27] All right. Let's get to our Melissa Adhan right now in Cameroon, because she's following Pope Leo [4:31] during his first papal trip to Africa. The Trump administration is really doubling down on its [4:36] criticism of Pope Leo and his comments on the war with Iran. And it's still a top trend [4:42] right now. Melissa, what do you say? Hey, Gio. Hello from Cameroon. This is the second stop [4:49] for Pope Leo's historic papal visit. And let me tell you, it was incredible to see all of the [4:55] people that lined up the streets here. It was filled with thousands of people. They were cheering on as [5:00] they waved. They saw our journalist van. And then when they got just a little glimpse of the Pope as [5:05] he's made his way here into the capital city of Cameroon. Look, a third of the population here, [5:11] they are Catholics and they are very excited to have Pope Leo here. But I do want to share that [5:18] on our way here, we were able to listen and hear from Pope Leo himself. This is when he talked about [5:24] his trip to Algeria. And it was really interesting, Gio, because while he did not, of course, bring up [5:29] President Trump or VP Vance, despite their comments that they have made, Pope Leo did make it a point to [5:36] stress that why he's here. His trip to Algeria, in fact, is so key to help bring together different [5:43] religions, bridging together Christians and Muslims. Gio. All right, Melissa, Don there in Cameroon, [5:49] thank you. Let's bring in our Stephen Portnoy now for more on this because he covers politics. He [5:54] covers all things White House for us. And boy, oh boy, you have a lot to cover here because Stephen, [5:59] we're looking at what Vice President J.D. Vance said at this event. He was basically talking [6:04] at this Turning Point event. He was talking about Pope Leo, and people are searching for what he [6:09] said. He was down in Athens, Georgia, Gio, at an event put on by the group founded by the late [6:14] Charlie Kirk. It was last night. J.D. Vance, who became a Catholic in 2019, said the Pope needs to [6:20] be careful when he talks about matters of theology. The way J.D. Vance explained it as Vice President of [6:28] the United States, he, Vance, has to be careful when he talks about matters of public policy. [6:33] He says the Pope was wrong to say in recent days that anyone who is a disciple of Christ [6:38] is never on the side of those who once wielded the sword and today drop bombs. Now, J.D. Vance says [6:46] God was on the side of the Americans who liberated Europe from the Nazis. So he says the Pope has to [6:52] be careful and be sure that his comments on theology are anchored in the truth. There's been a pretty clear [6:59] response today from Catholic leaders, including the U.S. Conference of Catholic Bishops, [7:02] which issued a statement today that referred to Pope Leo as the supreme pastor of the church. [7:08] And responding to something that Vance specifically said last night about Catholic teachings on just [7:13] wars, the statement says that the long tradition of just wars is what the Pope has carefully [7:19] referenced in his comments on war. So the official position of American bishops is the Pope is already [7:24] being careful. Well, and Stephen, obviously this all started because President Trump was sending out [7:31] this truth social post about Pope Leo, and that's what got everything going here. So what is the [7:36] Trump administration saying right now about all of this? The president's continuing this back and [7:41] forth. He notes the Pope's criticism of the Iran war. Just before midnight last night, the president [7:45] posted on social media, will someone tell Pope Leo that Iran has killed 42,000 innocent, completely [7:52] unarmed protesters in the last two months, and that for Iran to have a nuclear bomb is completely [7:57] unacceptable. Trump also last night posted an image of himself being embraced by Jesus. Of course, [8:03] there was that AI generated picture he posted the other night that had him himself seeming very [8:07] Jesus-like. The president said he thought that image had him looking like a doctor. [8:13] All right, Stephen Portnoy, thank you so much for following all the details here. All right, [8:18] so let's go to our third search story here, and it's an appeals court blocking a federal judge [8:23] from conducting a contempt investigation into the Trump administration's Alien Enemies Act [8:28] deportations. Armando Garcia is with me here, and he covers immigration for us, and he knows all about [8:33] those deportation flights. So a lot of searches on this today, Armando. What do we know? [8:41] Well, Judge Bozberg currently serves as the chief judge of the D.C. District Court. He has presided over [8:46] several high-profile cases involving the Trump administration, including this one. This case [8:51] stems from March 2025, when the Trump administration invoked the rarely used Wartime Authority Alien [8:56] Enemies Act to essentially send 200 men, over 200 men, to the notorious prison in El Salvador known [9:03] as Secot, declaring that they were members of Trenderagua with little to no due process. [9:08] Bozberg wanted to investigate why the Trump administration defied his order to literally [9:12] turn the planes around and to pause the investigation, pardon, to pause the deportation, rather. [9:18] The court here said that, well, he couldn't do that. [9:22] Armando, why did the appeals court say that he must end his contempt investigation? [9:29] Well, two out of three judges said that it would have been an encroachment of the autonomy of the [9:33] executive branch. However, this might not be over yet. The ACLU says that they're now going to be [9:38] seeking what's called an en banc review of this decision. That essentially means that instead of a [9:43] panel of three judges, it's going to be the entire court that's going to review this decision. So we're [9:48] going to have to wait to see if that happens and what happens with that decision. [9:51] All right. Armando Garcia, thank you so much. We appreciate it. All right. So it is time to go [9:56] look at the other top searches because there's more happening on your timeline. Let's get back to [10:00] Maya. So Maya, what other stories are we looking at here? [10:03] Gio, it's the day so many people dread. Tax day is officially here. And search data is pure and absolute [10:09] chaos from people who waited until the very last day to file. We're seeing breakout questions like how to do [10:15] my taxes for free and a spike in people literally asking how many hours does it take to file as they [10:20] try to figure out if they can still do it, finish it by midnight tonight. But the good news is a ton of [10:26] restaurants and fast food chains are offering tax day food deals. So you can grab free nuggets from [10:32] Wendy's, followed up with a free foot lug from some way, and then wash it all down with a free donut from [10:37] Krispy Kreme as you finish filing. I don't know. Krispy Kreme sounds really good. What about you, Gio? Which one would you [10:42] pick? I mean, we need a little sugar after all that stress with tax day. All right. Thank you, Maya. We [10:47] appreciate it. All right. Coming up here, one search always leads to another. You know that. We've got a trending [10:51] topic, but that's just the surface. And this one is about peptides and the social media craze behind it. It's a [10:58] spiral and it's next. All right. Welcome back to search. Today's top searches are only part of the story. A simple [11:12] scroll can sometimes take you down that deep rabbit hole. It's time now for the spiral. All right. So you guys can stop [11:25] asking questions about peptides. It is a huge health trend that's going crazy online right now. So we're [11:30] following your clicks and your curiosity. And it looks like you guys also want to know about what [11:35] those peptides actually are and what they're used for and what to know about influencers using and [11:41] talking about it online. I know you're all seeing that. So let's break it down. We've got Dr. Darian [11:45] Sutton up first. Then we're going to chat with fitness influencer and trainer Joel Friedman, also here. [11:50] Guys, thank you for joining us. All right. So Darian, let's start with you because we're seeing this rise [11:55] and popularity of peptides being pushed online. And Darian, you've been following this craze for [12:00] quite a while for us now. So you're a board certified emergency medicine physician. You guys also love [12:06] him on social media with his TikTok. So what are peptides? Break it down for us. You're right, [12:12] Gio. These peptides are incredibly popular. You know, they're marketed for anything, including [12:17] weight loss, muscle building, anti-aging, and even recovery. So Gio, at its core, peptides are small [12:22] pieces of protein that act as messages in the body. They have the opportunity to tell cells what [12:28] to do and they can signal systems. The problem is, is that they're often marketed as quick and [12:33] targeted. But unfortunately, these systems are often complex and nuanced. And Gio, that is where [12:38] risk comes into play here. That is right, of course. And why is the FDA weighing, easing these [12:44] regulations? That's a big headline that people are saying that they're easing regulations. [12:48] Well, the FDA is looking at providing access to these peptides through compounding pharmacies. [12:54] We learned a lot about compounding through the GLP-1 phase and craze of many people going to [12:59] pharmacies to get GLP-1s at cheaper options and to improve access. But important to note here, [13:05] compounding pharmacies are meant to provide access to those patients with specific needs. [13:09] And in order to do that, they often go around certain FDA regulations and processes. [13:14] So even with allowing products like peptides through compounding pharmacies, [13:18] it still provides option, excuse me, it still provides opportunity for increased risk because [13:22] they haven't done that robust long-term studies. And that, of course, it increases the risk to the [13:27] patient when you don't for sure know exactly what type of peptide you're getting. And unfortunately, [13:32] that can lead to inappropriately activating a system in your body. And that can lead to outcomes [13:36] that increases risk, side effects, and adverse outcomes. Which ones might doctors recommend? [13:43] You know, peptide-based medications, there's over 100 different types of them. Some of them [13:48] are quite common, including things like insulin and the entire GLP-1 market. Those are peptide-based [13:53] options. But when you see a lot of these options that are marketed for fat burning or weight loss, [13:58] there are no current FDA-approved peptides in that space. And so doctors, you will not see doctors [14:03] recommending or providing these peptides through prescription-based formats unless they are peptide-based [14:08] medications that have already been FDA-approved. And again, those are for common conditions or specific [14:14] diagnosis that a patient is suffering from. You mentioned risks a little earlier. What are the [14:18] risks? So there's a couple of risks when you're injecting a substance that doesn't have robust human [14:24] studies and long-term trials. Number one, you're running the risk of infection and contamination. [14:29] And that contamination can include bacterial incontamination or contamination of foreign bodies [14:33] or foreign products. It's also simply the uncertainty of knowing exactly what's in the product. [14:38] When you're using a product that doesn't have robust human studies or long-term trials, [14:42] you're essentially participating in a large uncontrolled experiment. And that, of course, [14:46] is where risk comes into play. And in terms of the outcomes, many people will talk about [14:50] anecdotal experiences of possible benefits with peptides. But important to note here, [14:54] that's where data comes into play because anecdotal experiences are great. They provide interest, [14:59] but the science hasn't caught up in that gap. That gap, GEO, is where risk lies. [15:03] Okay. All right, Dr. Jerrion Sutton, stand by here just a moment because I have another question for you [15:07] coming up. But let's go to health and fitness trainer, Joel Freeman, who's joining us now for [15:11] more on his personal experience using peptides. Joel, it's good to see you. So what drew you to [15:16] using these non-FDA approved experimental peptides? Did you do your own research here? [15:23] Well, obviously I did my research, but then I also worked with an actual team, a medical doctor and [15:29] a hormonal optimization team that we went over all the options to decide what would most benefit me [15:36] based on what I was already doing in my health and fitness on the daily. [15:41] Was it easy to get your hands on these peptides? [15:45] It's very easy to get your hands on peptides now. For me, everything that I take is prescriptive [15:51] in terms of it actually has my name on it. I can't order it offline. I just can't go to a website on [15:56] the anything and just order it. And that was important to me. I don't want to take anything. [16:01] And especially as an influencer now and doing this for over 20 years, I want to make sure that [16:05] anybody that's following me sees what I do and I'm able to talk about it and let them know my [16:09] journey, but also in a safe way. As we know, you know, the big thing with FDA is the doctor just [16:15] was talking about. It's still very new and very uncharted, but the trend is not waiting for that. [16:21] Do you see or feel a difference with them? [16:24] I do. I do. I've been on, my journey has been about three years since I've started and also came [16:29] with hormone replacement therapy, testosterone replacement therapy as I hit 40. And it was one of those [16:36] things where, yes, I started feeling great, but it was in hand with the fundamentals, with sleep, [16:43] with exercise, with the nutrition aspect of it. And that's what is most important is that you can't [16:48] just take one peptide and you're like, hey, I'm going to wake up and I'm going to be skinny tomorrow [16:51] or I'm going to sleep better tonight. That's not how it works. You still have to nail the fundamentals. [16:55] So they are enhancers and they are amazing when done correctly and safely. [17:00] Joel, obviously, as we just reported here, we have not seen these human trials that show that they are safe [17:05] right now. Does that make you anxious? Because unlike FDA approved drugs, there's really nobody [17:10] checking what's in that vial or the package. It doesn't make me anxious because I work with [17:16] people that I trust in terms of my medical team, the hormonal team. These are licensed medical doctor [17:22] and people who are experts in their fields when it comes to these amino branch chains, [17:27] amino acids and everything like that. So I trust them. And that's the biggest thing. Now, [17:31] I would not be taking something that I could just go ahead and get online. I wouldn't be taking [17:36] something that I could just buy from anybody. But it is one of those things where, yeah, it's still [17:41] very, very new. And I think the research is going to show, as it already has in a lot of ways, [17:45] how some of these peptides can be beneficial. And I hope the messaging gets out that it's not that [17:49] magic pill. It's not the one-stop shop. It's just, it's a whole, it just, it works together with [17:55] everything else. That's such an important message that it's not a magic pill. What conversations are you [17:59] seeing right now surrounding peptides online? Where can I get them? That's pretty much where [18:05] everybody wants. They want to know where can they get them and how fast can they get them and how [18:08] cheap can they get them, right? So that is obviously what's trending right now. And companies have been [18:13] popping up all over the market and, you know, they're white labeling peptides. It's easier than [18:17] ever to get them. And, you know, I tell people, I look, you know, I'm not getting, my advice is just [18:21] be careful. Know who you're talking to. I tell everybody if they really want my opinion is to make sure [18:27] that you talk to a medical professional, someone who is licensed to have these conversations that [18:33] knows your body because every single person is different in terms of your age and your hormones. [18:37] And they all do work together, but you've got to be careful in doing that. And that's why I [18:42] wouldn't take anything without the opinions of the people that I trust. But yeah, they're very easy [18:47] to get. And that's what everybody asks me. And then, you know, people are impatient. They want the [18:51] results fast. They do. They do. All right. Joel Freeman, thank you so much. We appreciate it. [18:55] All right. So we just heard from Joel what you would do. So Dr. Darian Sutton, tell us, [19:01] what would you advise people who have an interest in peptides? [19:05] You know, I think that interest is valid. I can completely understand that. I'm also online. I [19:09] see the advertisements. I see the content. And I know that it's very engaging. Joel made up a great [19:14] point. He's got a specific medical team that is following him. When you're injecting these [19:18] substances like peptides, you hope that they target specific pathways. But because they're not FDA [19:23] approved, and because we don't have robust studies, there's a chance that they may unintentionally [19:28] target other pathways. That is what leads to adverse outcomes. That can lead to hormone imbalances, [19:33] functional dysfunction, or excuse me, dysfunction with your normal functions in your body. And [19:38] unfortunately, that can also lead to the development of abnormal cells. And that is the basis for [19:42] cancer. So it is so important that when you're using any therapy, especially if it's not FDA [19:47] approved, that you have the guidance of someone who understands how to treat the risks and also the [19:52] complications. It's about communication and trust. All right, Dr. Darian Sutton, thank you so much. We [19:57] appreciate it. All right, still ahead. It might be the top of your feed, but what's the vibe? We've got your top [20:02] pop culture and entertainment searches with Roxy Diaz, including the Material Girl blessing us with [20:07] another album. Of course, we're talking about Madonna. It's the vibe next. All right, it's time now for our vibe [20:28] check. Look at what's buzzing in entertainment and pop culture. Roxy Diaz joins me now with more on what's [20:33] trending on your feed. So Roxy, what's the vibe? I got it for you, Gio. And unfortunately, I gotta [20:38] start off with some not so good vibes. Actress Ruby Rose is accusing Katy Perry of sexual assault. [20:43] Rose says she filed an official police report against Perry, claiming that the assault happened [20:48] at an Australian nightclub in 2010. Katy Perry is denying the claims. A representative for the [20:53] pop star saying, Ruby Rose's allegations are not only categorically false, they're dangerous, [20:59] reckless lies, adding, quote, Ms. Rose has a well-documented history of making serious public [21:04] allegations on social media against various individuals, claims that have been repeatedly [21:09] denied by those names. Now, Ruby Rose has not responded to those claims by Perry's reps. And Gio, you know, [21:16] leaks happen all the time, but it's rare for an entire movie to surface early. And that's what [21:23] reportedly happened to Paramount's The Legend of Aang, The Last Airbender. The film was scheduled to be [21:28] released later this year, introducing fans to an older version of Aang and his friends. But earlier [21:34] this month, a user on X claimed Nickelodeon accidentally emailed them the full movie soon [21:40] after what appeared to be the complete film began spreading across social media online. Now, fans are [21:46] wondering whether The Legend of Aang will still be available to stream as planned. Paramount has not [21:52] responded to the alleged leak. And in other music news, Ye, formerly known as Kanye West, is facing [21:58] backlash over his anti-Semitic past. The rapper taking to social media to say that he takes full [22:04] responsibility for his actions, but added that he doesn't want to put his fans in the middle of it. [22:09] The comments come after French officials warn that they would block Ye from performing at a planned [22:14] concert in Marseille, saying that they would not allow him to, they would not allow the city to become [22:20] a showcase for those who promote hatred. Now, West ultimately chose to postpone the show himself. [22:25] The decision comes one week after London's Wireless Festival was canceled after Ye was announced as [22:31] the headliner. And in brighter news, one that you're going to love, Gio, pop icon Madonna is hitting the [22:37] dance floor once again, announcing her album Confession 2 is set to release on July 2nd. It's the long-awaited [22:44] sequel to her 2005 album Confession on the Dance Floor. She shared a snippet of the potential song [22:50] on the album, where she whispers, honestly, I wish I could be like other people and just not care, [22:56] but out here on the dance floor, I feel so free. So here's the question, Gio. [23:02] What do your dance floor moves look like? I know you got them. [23:06] I'm not going to fall for that. I'm not going to show you the moves, but I'm telling you, [23:09] I was at a Madonna concert, the most recent one. So, so, so good. So good. So congratulations to [23:14] her. Definitely. All right, Roxy. Thank you so much. I'm Gio Benitez. This is Searched on ABC News [23:19] Live, where your questions meet real answers. We're going to leave you with what's trending right now [23:23] on abcnews.com. And you see that QR code, you can scan that and you can catch up. We will catch you [23:28] back here tomorrow. See you then. Bye.

Transcribe Any Video or Podcast — Free

Paste a URL and get a full AI-powered transcript in minutes. Try ScribeHawk →